Tag: Herceptin

Blood clots are a reported serious side effect associated with Herceptin (trastuzumab), though the link is often complex and influenced by other factors inherent to cancer and its treatment. While Herceptin's main side effects typically involve the heart and lungs, patients should be aware of the signs and risks of blood clots during therapy.

Approximately 15-20% of invasive breast carcinomas overexpress the HER2 protein, a key target for specific cancer therapies [1.4.7]. For these cancers, a common question is, 'What's another name for trastuzumab?' The most widely known is the original brand name, Herceptin [1.2.2].